These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12154611)

  • 21. Prescribing behaviors of family physicians in the treatment of osteoarthritis.
    Holt WS; Mazzuca SA
    Fam Med; 1992; 24(7):524-7. PubMed ID: 1397826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prescribing and adverse reactions of nonsteroidal antiinflammatory drugs in general practice: a Dunedin study.
    Taylor D; Clark DW; Dovey SM; Tilyard MW
    N Z Med J; 1994 Jul; 107(981):263-6. PubMed ID: 8022581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
    Haag MD; Bos MJ; Hofman A; Koudstaal PJ; Breteler MM; Stricker BH
    Arch Intern Med; 2008 Jun; 168(11):1219-24. PubMed ID: 18541831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population.
    Rahme E; Choquette D; Beaulieu M; Bessette L; Joseph L; Toubouti Y; LeLorier J
    Am J Med; 2005 Nov; 118(11):1262-70. PubMed ID: 16271911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.
    Chan FK
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):563-73. PubMed ID: 17008926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.
    Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J
    Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.
    Lewis JD; Bilker WB; Brensinger C; Farrar JT; Strom BL
    Am J Gastroenterol; 2002 Oct; 97(10):2540-9. PubMed ID: 12385436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesia in soft-tissue injury: current practice in Auckland is not supported by the available evidence.
    Jones PG
    N Z Med J; 1999 Oct; 112(1097):376-9. PubMed ID: 10587068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
    Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
    Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prescription of non-steroidal anti-inflammatory agents and risk of iatrogenic adverse effects: a survey of 1072 French general practitioners].
    Coste J; Hanotin C; Leutenegger E
    Therapie; 1995; 50(3):265-70. PubMed ID: 7667811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What do patients in rheumatologic care know about the risks of NSAIDs?
    Ornbjerg LM; Andersen HB; Kryger P; Cleal B; Hetland ML
    J Clin Rheumatol; 2008 Apr; 14(2):69-73. PubMed ID: 18391673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.
    Taha AS; Angerson WJ; Prasad R; McCloskey C; Gilmour D; Morran CG
    Aliment Pharmacol Ther; 2008 Oct; 28(7):878-85. PubMed ID: 18644010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?
    Kasje WN; Denig P; de Graeff PA; Haaijer-Ruskamp FM
    BMC Fam Pract; 2005 May; 6(1):19. PubMed ID: 15869704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R; Rubin G; Berenbaum F; Scheiman J
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
    Salvatierra Laytén G; de la Cruz Romero L; Paulino Merino M; Vidal Vidal V; Rivera Dávila C; Cano Chuquilin A; Frisancho Velarde O
    Rev Gastroenterol Peru; 2006; 26(1):13-20. PubMed ID: 16622483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sore throat management in New Zealand general practice.
    Kljakovic M; Crampton P
    N Z Med J; 2005 Aug; 118(1220):U1609. PubMed ID: 16132070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the benefits and risks of drugs. The example of NSAIDs.
    Henry D
    Aust Fam Physician; 1990 Mar; 19(3):378-83, 385, 387. PubMed ID: 2185729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.